ANI Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US00182C1036

SecurityANIP / ANI Pharmaceuticals, Inc.
InstitutionSei Investments Co
Latest Disclosed Ownership41,801 shares
Latest Disclosed Value $ 3,300,663
Sei Investments Co reports 78.49% increase in ownership of ANIP / ANI Pharmaceuticals, Inc.

On February 13, 2026 - Sei Investments Co filed a 13F-HR form disclosing ownership of 41,801 shares of ANI Pharmaceuticals, Inc. (US:ANIP) valued at $3,299,771 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 23,419 shares of ANI Pharmaceuticals, Inc.. This represents a change in shares of 78.49% during the quarter. The current value of the position is $3,144,689 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ANI PHARMACEUTICALS COM 00182C103 41,801 18,382 78.49 3,301 53.92 0.0033
2025-11-13 2025-09-30 13F ANI PHARMACEUTICALS COM 00182C103 23,419 14,753 170.24 2,145 279.47 0.0023
2025-08-14 2025-06-30 13F ANI PHARMACEUTICALS COM 00182C103 8,666 -1,375 -13.69 565 -15.92 0.0007
2025-05-14 2025-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 10,041 -12,733 -55.91 672 -46.58 0.0009
2025-05-13 2025-03-31 13F ANI PHARMACEUTICALS COM 00182C103 22,774 0 1,259 0.0014
2025-02-11 2024-12-31 13F ANI PHARMACEUTICALS COM 00182C103 22,774 2,752 13.74 1,259 5.36 0.0016
2024-11-12 2024-09-30 13F ANI PHARMACEUTICALS COM 00182C103 20,022 5,549 38.34 1,195 29.64 0.0016
2024-08-13 2024-06-30 13F ANI PHARMACEUTICALS COM 00182C103 14,473 3,152 27.84 922 17.77 0.0013
2024-05-07 2024-03-31 13F ANI PHARMACEUTICALS COM 00182C103 11,321 1,594 16.39 783 45.90 0.0011
2024-02-14 2023-12-31 13F ANI PHARMACEUTICALS COM 00182C103 9,727 9,727 536 0.0009
2023-11-14 2023-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -12,568 -100.00 0 -100.00
2023-08-11 2023-06-30 13F ANI PHARMACEUTICALS COM 00182C103 12,568 -3,389 -21.24 677 6.79 0.0012
2023-05-12 2023-03-31 13F ANI PHARMACEUTICALS COM 00182C103 15,957 4,099 34.57 634 32.70 0.0012
2023-02-10 2022-12-31 13F ANI PHARMACEUTICALS COM 00182C103 11,858 11,858 477 0.0011
2019-11-12 2019-09-30 13F ANI PHARMACEUTICALS COM 00182C103 0 -2,531 -100.00 0 -100.00
2019-08-14 2019-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,531 -43 -1.67 206 15.73 0.0007
2019-05-15 2019-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,574 1,542 149.42 178 223.64 0.0006
2019-02-13 2018-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,032 253 32.48 55 27.91 0.0002
2018-11-08 2018-09-30 13F ANI PHARMACEUTICALS COM 00182C103 779 -2,007 -72.04 43 -76.88 0.0002
2018-08-03 2018-06-30 13F ANI PHARMACEUTICALS COM 00182C103 2,786 534 23.71 186 41.98 0.0006
2018-05-11 2018-03-31 13F ANI PHARMACEUTICALS COM 00182C103 2,252 817 56.93 131 40.86 0.0005
2018-02-08 2017-12-31 13F ANI PHARMACEUTICALS COM 00182C103 1,435 -186 -11.47 93 9.41 0.0003
2017-11-06 2017-09-30 13F ANI PHARMACEUTICALS COM 00182C103 1,621 464 40.10 85 54.55 0.0003
2017-07-31 2017-06-30 13F ANI PHARMACEUTICALS COM 00182C103 1,157 402 53.25 55 44.74 0.0002
2017-05-05 2017-03-31 13F ANI PHARMACEUTICALS COM 00182C103 755 330 77.65 38 52.00 0.0002
2017-02-02 2016-12-31 13F ANI PHARMACEUTICALS COM 00182C103 425 118 38.44 25 19.05 0.0001
2016-11-04 2016-09-30 13F ANI PHARMACEUTICALS COM 00182C103 307 267 667.50 21 950.00 0.0001
2016-08-11 2016-06-30 13F ANI PHARMACEUTICALS COM 00182C103 40 40 0.00 2 0.0000
2016-05-10 2016-03-31 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 0 0 0 0.0000
2016-02-03 2015-12-31 13F ANI PHARMACEUTICALS COM 00182C103 0 -2,100 -100.00 0 -100.00
2015-11-02 2015-09-30 13F/A-1 ANI PHARMACEUTICALS COM 00182C103 2,100 2,100 83 0.0008
2015-10-30 2015-09-30 13F ANI PHARMACEUTICALS COM 00182C103 2,100 83
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.